Chooze Corp

Chooze Corp is a San Diego-based biotechnology company focused on the discovery and development of novel therapeutic antibodies for oncology. Led by industry veteran Robert Kramer, the company utilizes a proprietary functional selection platform designed to identify antibodies with specific biological activities against challenging targets. By focusing on functional outcomes rather than simple binding, Chooze aims to develop more effective precision medicines for patients with high unmet medical needs. The company is currently in the pre-clinical stage, advancing a pipeline of candidates targeting various cancer pathways.